Derm-Biome Pharmaceuticals, Inc. is a Vancouver based preclinical biopharmaceutical company focused on advancing safe and effective topical therapies for inflammatory skin diseases and skin cancer, each of which represents a significant unmet clinical need.
View Top Employees from Derm-Biome Pharmaceuticals, IncWebsite | http://derm-biomepharmaceuticals.com |
Revenue | $1 million |
Funding | $500000 |
Employees | 3 (1 on RocketReach) |
Founded | 2018 |
Address | 638 Beach Crescent, 1201, Vancouver, British Columbia V6Z 3H4, CA |
Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
Industry | Hospitals and Health Care, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 33 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies |
Looking for a particular Derm-Biome Pharmaceuticals, Inc employee's phone or email?
The Derm-Biome Pharmaceuticals, Inc annual revenue was $1 million in 2024.
1 people are employed at Derm-Biome Pharmaceuticals, Inc.
Derm-Biome Pharmaceuticals, Inc is based in Vancouver, British Columbia.
The NAICS codes for Derm-Biome Pharmaceuticals, Inc are [5417, 33, 541, 54, 54171, 541711].
The SIC codes for Derm-Biome Pharmaceuticals, Inc are [283, 28, 80].